Concepedia

Liselotte Tas

LT

Statistics

Publications

5

Citations

143

H-Index

5

Active since

2018

Affiliations

Oncode Institute(Current)

Erasmus MC

The Netherlands Cancer Institute

Erasmus University Rotterdam

Liselotte Tas is an author at Oncode Institute specializing in autoimmune diseases, primary sjögren syndrome, and sjögren syndrome.

Publications per year

2018–2025

5

Publications

5

TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis

Iris L. A. Bodewes, Erika Huijser, Cornelia G van Helden-Meeuwsen et al. · Journal of Autoimmunity · 2018 · 67 citations · Full text

, , +13

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy

Kim E. Kortekaas, Saskia J. Santegoets, Liselotte Tas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 27 citations · Full text

, , +17

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets

Iris L. A. Bodewes, Peter J. van der Spek, Leticia G. León et al. · Frontiers in Immunology · 2019 · 25 citations · Full text

, , +17

Tumour-reactive heterotypic CD8 T cell clusters from clinical samples

Sofia Ibáñez‐Molero, J. E. Veldman, Juan Simon Nieto et al. · Nature · 2025 · 13 citations · Full text

, , +17

Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series

Catriona Harvey, Kazi Nahar, Janet McKeown et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

, , +17

1–5 of 5